Forskarna jobbar hårt på det men skillnader mellan däggdjur komplicerar "plan Ozempic".
https://www.independent.co.uk/news/uk/home-news/ozempic-dogs-pets-health-obesity-b2809766.html
With up to 60 per cent of dogs in the UK estimated to be overweight or obese, the market for such drugs could be considerable.
Okava, a San Francisco-based bio-pharma company which specialises in pet health, is planning to run trials for a drug designed to mimic the effects of Ozempic, with the goal to produce an implant-version for dogs, which lasts six-months at a time.
According to estimates on the company's website, the current market for such a product could be worth $10bn, and they hope to have a canine weight-loss drug available as early as 2028 or 2029. "